Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05948631 · ClinicalTrials.gov registry record · NA
MISC-IPV: a Community-Based Intervention for Children Traumatized by Intimate Partner Violence
A NA study of Treatment as Usual and MISC Intervention, sponsored by University of Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT05948631: Recruiting NA study of Treatment as Usual and MISC Intervention, sponsored by University of Houston.
NCT05948631 is a NA study of Treatment as Usual and MISC Intervention that is actively recruiting participants, run by University of Houston. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05948631, a NA study of Treatment as Usual and MISC Intervention, is actively recruiting participants, sponsored by University of Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
This study adapts and evaluates preliminary outcomes of the Mediational Intervention for Sensitizing Caregivers (MISC) for women and children of color who have survived domestic violence.
Primary Outcome
The primary outcome measure is change in mental health outcomes as assessed through by the Strengths and Difficulties Questionnaire (SDQ). The SDQ total score indexes the overall level of mental health problems a child is experiencing with a minimum score of 0 and a maximum score of 60. A higher the score indicates higher the levels of mental health problems.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual (TAU)
- BEHAVIORAL MISC intervention
Study Locations (1)
Texas
- University of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What NCT05948631 shows while recruiting
NCT05948631 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Treatment as Usual appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT05948631 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05948631 about?
NCT05948631 is a clinical study titled "MISC-IPV: a Community-Based Intervention for Children Traumatized by Intimate Partner Violence". This study adapts and evaluates preliminary outcomes of the Mediational Intervention for Sensitizing Caregivers (MISC) for women and children of color who have survived domestic violence.
What is the current status of trial NCT05948631?
This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2023-02-14. Estimated completion is 2025-04-30.
What conditions does trial NCT05948631 study?
This clinical trial studies the following conditions: Treatment as Usual, MISC Intervention.
What interventions are being tested in trial NCT05948631?
The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), MISC intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05948631?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05948631 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Treatment as Usual
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05948631's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI